Ken Kang-Hsin Wang

Prof. Ken Kang-Hsin Wang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KTKekoa Taparra
Kekoa Taparra
HWHailun Wang
Hailun Wang
RMReem Malek
Reem Malek
ALAudrey Lafargue
Audrey Lafargue
MBMustafa A. Barbhuiya
Mustafa A. Barbhuiya
PTPhuoc Tran
Phuoc Tran
Mutant KRAS drives glycolytic flux in lung cancer, potentially impacting aberrant protein glycosylation. Recent evidence suggests aberrant KRAS drives flux of glucose into the hexosamine biosynthetic pathway (HBP). HBP is required for various glycosylation processes, such as protein N- or O-glycosylation and glycolipid synthesis. However, its function during tumorigenesis is poorly understood. One contributor and proposed target of KRAS-driven cancers is a developmentally conserved epithelial plasticity program called epithelial-mesenchymal transition (EMT). Here we showed in novel autochthonous mouse models that EMT accelerated KrasG12D lung tumorigenesis by upregulating expression of key enzymes of the HBP pathway. We demonstrated that HBP was required for suppressing KrasG12D-induced senescence, and targeting HBP significantly delayed KrasG12D lung tumorigenesis. To explore the mechanism, we investigated protein glycosylation downstream of HBP and found elevated levels of O-linked β-N-acetylglucosamine (O-GlcNAcylation) posttranslational modification on intracellular proteins. O-GlcNAcylation suppressed KrasG12D oncogene-induced senescence (OIS) and accelerated lung tumorigenesis. Conversely, loss of O-GlcNAcylation delayed lung tumorigenesis. O-GlcNAcylation of proteins SNAI1 and c-MYC correlated with the EMT-HBP axis and accelerated lung tumorigenesis. Our results demonstrated that O-GlcNAcylation was sufficient and required to accelerate KrasG12D lung tumorigenesis in vivo, which was reinforced by epithelial plasticity programs.

1 April 2016 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
BZBin Zhang
Bin Zhang
KWKen Kang-Hsin Wang
Ken Kang-Hsin Wang
JYJingjing Yu
Jingjing Yu
SESohrab Eslami
Sohrab Eslami
IULIAN IORDACHITAIULIAN IORDACHITA
IULIAN IORDACHITA
JWJohn W. Wong
John W. Wong

2 May 2016 in Medical Physics
Verified
Journal Article
Closed access
JYJingjing Yu
Jingjing Yu
BZBin Zhang
Bin Zhang
IULIAN IORDACHITAIULIAN IORDACHITA
IULIAN IORDACHITA
JRJuvenal Reyes
Juvenal Reyes
ZLZhihao Lu
Zhihao Lu
KWKen Kang-Hsin Wang
Ken Kang-Hsin Wang

1 March 2020 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
ZDZijian Deng
Zijian Deng
XXXiangkun Xu
Xiangkun Xu
TGTomas Garzon-Muvdi
Tomas Garzon-Muvdi
YXYuanxuan Xia
Yuanxuan Xia
EKEileen Kim
Eileen Kim
KWKen Kang-Hsin Wang
Ken Kang-Hsin Wang

1 July 2014 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
KWKen Kang-Hsin Wang
Ken Kang-Hsin Wang
NVNeha Vapiwala
Neha Vapiwala
VBViet Bui
Viet Bui
CDCurtiland Deville
Curtiland Deville
JPJohn P. Plastaras
John P. Plastaras
SBStefan Both
Stefan Both

1 December 2021 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Open access
XXXiangkun Xu
Xiangkun Xu
ZDZijian Deng
Zijian Deng
HDHamid Dehghani
Hamid Dehghani
IIIulian Iordachita
Iulian Iordachita
MLMichael Lim
Michael Lim
KWKen Kang-Hsin Wang
Ken Kang-Hsin Wang
Widely used cone beam computed tomography (CBCT)-guided irradiators in preclinical radiation research are limited to localize soft tissue target because of low imaging contrast. Knowledge of target volume is a fundamental need for radiation therapy (RT). Without such information to guide radiation, normal tissue can be overirradiated, introducing experimental uncertainties. This led us to develop high-contrast quantitative bioluminescence tomography (QBLT) for guidance. The use of a 3-dimensional bioluminescence signal, related to cell viability, for preclinical radiation research is one step toward biology-guided RT. Our QBLT system enables multiprojection and multispectral bioluminescence imaging to maximize input data for the tomographic reconstruction. Accurate quantification of spectrum and dynamic change of in vivo signal were also accounted for the QBLT. A spectral-derivative method was implemented to eliminate the modeling of the light propagation from animal surface to detector. We demonstrated the QBLT capability of guiding conformal RT using a bioluminescent glioblastoma (GBM) model in vivo. A threshold was determined to delineate QBLT reconstructed gross target volume (GTVQBLT), which provides the best overlap between the GTVQBLT and CBCT contrast labeled GBM (GTV), used as the ground truth for GBM volume. To account for the uncertainty of GTVQBLT in target positioning and volume delineation, a margin was determined and added to the GTVQBLT to form a QBLT planning target volume (PTVQBLT) for guidance. The QBLT can reconstruct in vivo GBM with localization accuracy within 1 mm. A 0.5-mm margin was determined and added to GTVQBLT to form PTVQBLT, largely improving tumor coverage from 75.0% (0 mm margin) to 97.9% in average, while minimizing normal tissue toxicity. With the goal of prescribed dose 5 Gy covering 95% of PTVQBLT, QBLT-guided 7-field conformal RT can effectively irradiate 99.4 ± 1.0% of GTV. The QBLT provides a unique opportunity for investigators to use biologic information for target delineation, guiding conformal irradiation, and reducing normal tissue involvement, which is expected to increase reproducibility of scientific discovery.